US-Kazakhstan Trade Modernization Act

House Bill

H.R. 1024

119th Congress

US-Kazakhstan Trade Modernization Act

In Committee

Introduced:Oct 24, 2025

Primary Sponsor

Chris Pappas

D - NH

Cosponsors

24

Quick Stats

Policy Area

Health

Summary

This bill aims to reduce the use of animals in scientific research and testing by establishing a center within the National Institutes of Health (NIH) to promote the development and use of alternative research methods, such as advanced cell cultures and imaging systems. The bill would require federal agencies and entities that receive federal funding to create and update plans for reducing their use of animals, and make these plans publicly available.

Latest Action

Referred to the Subcommittee on Health.

Introduced10/24/2025

StatusReferred to the House Committee on Ways and Means.

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

US-Kazakhstan Trade Modernization Act

This bill aims to reduce the use of animals in scientific research and testing by establishing a center within the National Institutes of Health (NIH) to promote the development and use of alternative research methods, such as advanced cell cultures and imagin

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill aims to reduce the use of animals in scientific research and testing by establishing a center within the National Institutes of Health (NIH) to promote the development and use of alternative research methods, such as advanced cell cultures and imaging systems. The bill would require federal agencies and entities that receive federal funding to create and update plans for reducing their use of animals, and make these plans publicly available.

Bill Number: 1024
Introduced: 10/24/2025
Status: Referred to the House Committee on Ways and Means.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: US-Kazakhstan Trade Modernization Act
Bill Number: 1024
Sponsor: No sponsor
Status: Referred to the House Committee on Ways and Means.
Introduced: 10/24/2025
Summary: This bill aims to reduce the use of animals in scientific research and testing by establishing a center within the National Institutes of Health (NIH) to promote the development and use of alternative research methods, such as advanced cell cultures and imaging systems. The bill would require federa

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill aims to reduce the use of animals in scientific research and testing by establishing a center within the National Institutes of Health (NIH) to promote the development and use of alternative research methods, such as advanced cell cultures and imaging systems. The bill would require federal agencies and entities that receive federal funding to create and update plans for reducing their use of animals, and make these plans publicly available.

Last updated: 12/29/2025

Official Summary

Congressional Research Service summary

Humane and Existing Alternatives in Research and Testing Sciences Act of 2022 [sic] or the HEARTS Act of 2022 [sic] This bill establishes a center within the National Institutes of Health (NIH) and requires other activities to promote alternatives to using animals in research and testing. The duties of the center include developing nonanimal research models (e.g., advanced cell cultures and advanced imaging systems) and training scientists about the methods. Additionally, if a federal department or agency or federally funded research entity uses animals for research and testing, it must develop and update plans for reducing such uses and periodically report on the number and types of animals that they use to the center. The center must establish a standard process for entities to submit and update their plans and reports and for making the plans and reports publicly available. The NIH must also provide incentives for the use of nonanimal research and generally ensure that nonanimal alternatives are considered when reviewing and approving research applications and proposals. Further, NIH applications for research grants must include an assurance that nonanimal methods for carrying out the research are unavailable.

Key Points

Main provisions of the bill

Establishes a center within the NIH to develop and promote alternatives to animal research and testing, such as advanced cell cultures and imaging systems.
Requires federal agencies and entities that receive federal funding to create and regularly update plans for reducing their use of animals in research and testing.
Mandates that these plans be made publicly available.
Requires the NIH to provide incentives for the use of non-animal research methods and ensure they are considered when reviewing and approving research proposals.
NIH grant applications must include an assurance that non-animal research methods are unavailable for the proposed work.

How This Impacts Americans

Potential effects on citizens and communities

If passed, this bill would affect the scientific research community, including universities, private companies, and government agencies that conduct animal research. It would require them to explore and implement alternative research methods, reducing the number of animals used in experiments. This could lead to more efficient and humane scientific research, benefiting both the animals and the researchers.

Policy Areas

Primary Policy Area

Health

Related Subjects

Animal protection and human-animal relationships

Executive agency funding and structure

Government information and archives

Medical research

National Institutes of Health (NIH)

Research administration and funding

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

1024, 119th Congress (2025). "US-Kazakhstan Trade Modernization Act". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-1024

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.